181 related articles for article (PubMed ID: 26577493)
1. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
[TBL] [Abstract][Full Text] [Related]
2. The CDKN2A-CDKN2B rs4977756 polymorphism and glioma risk: a meta-analysis.
Lu H; Yang Y; Wang J; Liu Y; Huang M; Sun X; Ke Y
Int J Clin Exp Med; 2015; 8(10):17480-8. PubMed ID: 26770338
[TBL] [Abstract][Full Text] [Related]
3. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
4. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
[TBL] [Abstract][Full Text] [Related]
5. Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.
Melin B; Dahlin AM; Andersson U; Wang Z; Henriksson R; Hallmans G; Bondy ML; Johansen C; Feychting M; Ahlbom A; Kitahara CM; Wang SS; Ruder AM; Carreón T; Butler MA; Inskip PD; Purdue M; Hsing AW; Mechanic L; Gillanders E; Yeager M; Linet M; Chanock SJ; Hartge P; Rajaraman P
Int J Cancer; 2013 May; 132(10):2464-8. PubMed ID: 23115063
[TBL] [Abstract][Full Text] [Related]
6. Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis.
Wu Y; Zhou J; Zhang J; Tang Z; Chen X; Huang L; Liu S; Chen H; Wang Y
Front Oncol; 2023; 13():1180099. PubMed ID: 37746290
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
Tao Y; Liang G
Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
[TBL] [Abstract][Full Text] [Related]
8. Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis.
Thakur N; Kupani M; Mannan R; Pruthi A; Mehrotra S
BMC Med Genomics; 2021 Jan; 14(1):1. PubMed ID: 33397358
[TBL] [Abstract][Full Text] [Related]
9. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
Wu Q; Peng Y; Zhao X
Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184
[TBL] [Abstract][Full Text] [Related]
10. Association between type 2 diabetes and CDKN2A/B: a meta-analysis study.
Bao XY; Xie C; Yang MS
Mol Biol Rep; 2012 Feb; 39(2):1609-16. PubMed ID: 21625859
[TBL] [Abstract][Full Text] [Related]
11. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
Xin Y; Hao S; Lu J; Wang Q; Zhang L
PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
[TBL] [Abstract][Full Text] [Related]
12. Assessing the association between EFEMP1 rs3791679 polymorphism and risk of glioma in a Chinese Han population.
Jiang N; Peng YP; Wang XY; Dou CW; He WM
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706619
[TBL] [Abstract][Full Text] [Related]
13. Association between GSTP1 Ile105Val polymorphism and glioma risk: a systematic review and meta-analysis.
Xie P; Liang Y; Liang G; Liu B
Tumour Biol; 2014 Jan; 35(1):493-9. PubMed ID: 23975366
[TBL] [Abstract][Full Text] [Related]
14. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
Zong H; Cao L; Ma C; Zhao J; Ming X; Shang M; Xu H
Tumour Biol; 2014 Aug; 35(8):8095-101. PubMed ID: 24840634
[TBL] [Abstract][Full Text] [Related]
15. The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: a meta-analysis.
Peng F; Hu D; Gu C; Li X; Li Y; Jia N; Chu S; Lin J; Niu W
Gene; 2013 Dec; 531(2):435-43. PubMed ID: 24012816
[TBL] [Abstract][Full Text] [Related]
16. Association between type 2 diabetes and rs10811661 polymorphism upstream of CDKN2A/B: a meta-analysis.
Li H; Tang X; Liu Q; Wang Y
Acta Diabetol; 2013 Oct; 50(5):657-62. PubMed ID: 22623142
[TBL] [Abstract][Full Text] [Related]
17. Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma.
Youn BJ; Cheong HS; Namgoong S; Kim LH; Baek IK; Kim JH; Yoon SJ; Kim EH; Kim SH; Chang JH; Kim SH; Shin HD
Mol Biol Rep; 2022 Nov; 49(11):10339-10346. PubMed ID: 36097105
[TBL] [Abstract][Full Text] [Related]
18. Two gene polymorphisms (rs4977756 and rs11515) in CDKN2A/B and glioma risk in South Indian population.
Sibin MK; Dhananjaya IB; Narasingarao KV; Harshitha SM; Jeru-Manoj M; Chetan GK
Meta Gene; 2016 Sep; 9():215-8. PubMed ID: 27617221
[TBL] [Abstract][Full Text] [Related]
19. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
Qian T; Zhang B; Qian C; He Y; Li Y
Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
[TBL] [Abstract][Full Text] [Related]
20. FTO, GCKR, CDKAL1 and CDKN2A/B gene polymorphisms and the risk of gestational diabetes mellitus: a meta-analysis.
Guo F; Long W; Zhou W; Zhang B; Liu J; Yu B
Arch Gynecol Obstet; 2018 Oct; 298(4):705-715. PubMed ID: 30074065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
